SNGX READ THE FULL SNGX RESEARCH REPORT Business Update CiVax™ Booster Enhances Protection from COVID-19 in NHPs On March 25, ...

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet ...

The global coronavirus immunoassay market continues to witness steady growth, reaching USD 3.7 billion in 2021 and is projected to exceed USD 6.9 billion by 2032, expanding at a CAGR of 5.5% during ...

Department of Applied Chemistry, Faculty of Science and Technology, Keio University, 3-14-1 Hiyoshi, Kohoku-ku, Yokohama, Kanagawa 223-8522, Japan ...

They then combined three editing technologies to edit the mouse genome—RNP-mediated knockout, multiplex precision genome editing, and precision homology-directed repair. They used these methods ...

Analyses of the manufacturer's more extensive data yielded similar results. The assay was reworked as a consequence, but was not removed from other markets during the interim period. NRL ...

Here, we apply these polymeric coacervates to develop an innovative sandwich immunoassay diagnostic platform, which we term a one-pot Selective Target Enrichment by Polymer (oneSTEP) immunoassay.

Developed using the Acrivon Predictive Precision Proteomics (AP3) platform, the multiplex immunofluorescence assay is currently being used in an ongoing, multicentre Phase IIb trial to detect ...